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Background: Parotid gland metastasis in lung cancer is extremely rare, very few cases have been reported.
Case presentation: We report on the case of a 61-year-old Chinese male patient who presented with parotid
swelling metastasizing from advanced lung cancer. We therefore performed an operation of partial parotidectomy
with preservation of the facial nerve and advised the patient receive chemotherapy, however, the patient died four
months later.
Conclusion: Although it is extremely rare, a potential metastasis of lung cancer should not be ignored in the
diagnosis of parotid tumor. Preoperative routine examination, such as a chest X-ray and lung computational
tomography scan, may play an important role in differential diagnosis. The management of the metastatic tumor
to the parotid gland was controversial however, despite combined treatment modalities, long-term survival was
not attained.
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Lung cancer is a common tumor worldwide and fre-
quently causes cancer-related deaths. It has a propensity
to metastasize to any organ. To the best of our know-
ledge, the site of parotid gland in this case is very un-
usual and only a few articles have reported [1-5]. We
describe a case of small-cell carcinoma of the lung which
spread to the parotid gland.Case presentation
A 61-year-old Chinese male presented with a progressive
painful swelling in the right parotid gland for one month
prior to attending our hospital. The patient had a history
of heavy smoking, but did not complain of hemoptysis
or other symptoms related to lung cancer. A clinical
examination showed the size of the mass to be approxi-
mately 1 × 1 cm, with a good activity and a moderate
texture. An ultrasound showed there to be a hypoechoic
nodule with a size of 1.3× 1.3 × 0.9 cm. Therefore our
initial diagnosis was that of a primary parotid tumor and* Correspondence: qigenfang@hotmail.com
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operative routine examinations, a chest X-ray (Figure 1)
showed there to be a high density shadow in the right
hilar. At this stage we highly suspected that the mass
was metastases and required further examination. A lung
computational tomography (CT) scan (Figure 2) revealed
a shadow in the right upper lobe, with a size of approxi-
mately 5.4 × 6.3 cm. The CT value was 40HU, and the en-
hanced CT value was 60HU, with multiple lymph nodes in
the mediastinum appearing enlarged. After consulting
with the patient, we performed an operation constituting
of a partial parotidectomy and facial nerve dissection.
Postoperative pathology reported a small-cell lung can-
cer metastases to parotid (Figure 3). Immunohistochem-
istry showed TTF(thyroid transcription factor)-1(+), Syn
(Synaptophysin) (+), actin (−), S-100(−), P63 (−), EMA
(epithelial membrane antigen) (−), ck(cytokeratin)20
(−). Therefore, we recommended that the patient re-
ceive postoperative radiation and chemotherapy.
Discussion
Small-cell lung cancer comprises approximately 15% of
bronchogenic carcinomas. It has a high malignancy po-
tential and is usually associated with various paraneo-
plastic syndromes. At the time of diagnosis the disease is. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 A high density shadow in the right hilar (X-ray).
Figure 3 Pathology: diffusely infiltrating atypical monotone cells
in fibrous tissue. (Hematoxylin and eosin, original magnification × 200).
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diagnosis sometimes is made from a metastatic focus.
The common site of distant spread is the mediastinal
and supraclavicular lymph nodes, liver, bone, adrenals,
and brain [5,6]. However, distant metastasis to the par-
otid gland is a very rare clinical event, to the best of our
knowledge. The possible reasons for this may be the
anatomical location of the parotid gland and that paren-
chymal metastasis occurred via hematogenous rather
than by lymphatic spread.
As far as we are aware, it is a known fact that most of
the metastasis to the submandibular gland are from aFigure 2 A shadow in the right upper lobe (Lung CT).distant source, with much fewer being from the head
and neck area, which is exactly the opposite when com-
pared to the parotid gland. We hypothesize that the pos-
sible reasons for this situation are the difference in the
anatomic relationships, number of the lymph nodes, and
their drainage between the parotid gland and subman-
dibular gland.
The treatment of metastatic parotid tumor is a matter
of debate. Raut et al. [7] presented that, for most tumors
restricted to the parotid, a total parotidectomy whilst
protecting the facial nerve, followed by radiation ther-
apy, should be the protocol. Nuyens et al. [8] found that
the predominant amount of metastatic diseases to the
parotid gland were squamous cell carcinomas and malig-
nant melanomas, and concluded that a total or partial
parotidectomy with consideration for neck dissection,
followed by post-operation radiation, should be included
in the treatment. Bumpous et al. [9] reviewed related
cases and concluded that, when a positive lymph node
was detected in the parotid, a combination of surgical
management with postoperative irradiation could in-
crease locoregional control. However, Jecker et al. [10]
reported that radical parotid surgery had little effect on
improving the life expectancy and concluded that all the
current therapeutic procedures were ineffective. In our
view, for parotid gland metastases from head and neck
cancer origin, a total or partial parotidectomy with a neck
dissection is acceptable because of the tendency of the dis-
ease to spread via the lymphatic system. For parotid gland
metastases originating from a distant organ such as the
lung, a neck dissection may be unnecessary because the
metastasis is more likely to be caused by hematogenous.
In this case, we performed an operation consisting of a
partial parotidectomy with preservation of facial nerve,
and advised that the patient receive chemotherapy based
on the fact that small-cell lung cancer is sensitive to
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situation highlighted the fact that metastasis to the parotid
gland represented an advanced stage of the disease with a
subsequently poor prognosis [5].
Conclusions
Although it is extremely rare, a potential metastasis of
lung cancer should not be ignored in the diagnosis of a
parotid tumor. Preoperative routine examinations such
as a chest X-ray and lung CT, may play an important
role in the differential diagnosis. The management of the
metastatic tumor to the parotid gland was controversial,
however, despite combined treatment modalities long-
term survival remained unsuccessful.
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